The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -20.32%. However, over the past six months, we’ve seen a stronger performance of -28.52%. The price of IDYA leaped by -5.50% over the last 30 days. And in the last five days, it has surged by 5.86%.
The market performance of Ideaya Biosciences Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $47.74 on 02/15/24, while the lowest value for the same duration was $25.20 on 11/21/24.
52-week price history of IDYA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Ideaya Biosciences Inc’s current trading price is -40.61% away from its 52-week high, while its distance from the 52-week low is 12.50%. The stock’s price range during this period has varied between$25.20 and $47.74. The Ideaya Biosciences Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.13 million for the day, a figure considerably higher than their average daily volume of 0.88 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Ideaya Biosciences Inc (IDYA) has experienced a quarterly decline of -24.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.45B and boasts a workforce of 124 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 33.97, with a change in price of -13.00. Similarly, Ideaya Biosciences Inc recorded 783,718 in trading volume during the last 100 days, posting a change of -31.44%.
IDYA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for IDYA stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
IDYA Stock Stochastic Average
As of today, Ideaya Biosciences Inc’s raw stochastic average for the last 50 days stands at 42.17%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 42.17%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 30.61% and 28.16%, respectively.
